Bumrungrad Hospital PCL (BUHPF)
6.93
0.00 (0.00%)
USD |
OTCM |
Jun 28, 16:00
Bumrungrad Hospital Enterprise Value: 5.165B for June 27, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| June 27, 2024 | 5.165B |
| June 26, 2024 | 5.165B |
| June 25, 2024 | 5.165B |
| June 24, 2024 | 5.165B |
| June 21, 2024 | 5.165B |
| June 20, 2024 | 5.165B |
| June 18, 2024 | 5.165B |
| June 17, 2024 | 5.165B |
| June 14, 2024 | 5.165B |
| June 13, 2024 | 5.165B |
| June 12, 2024 | 5.165B |
| June 11, 2024 | 5.165B |
| June 10, 2024 | 5.165B |
| June 07, 2024 | 5.165B |
| June 06, 2024 | 5.165B |
| June 05, 2024 | 5.165B |
| June 04, 2024 | 5.165B |
| June 03, 2024 | 5.165B |
| May 31, 2024 | 5.165B |
| May 30, 2024 | 5.165B |
| May 29, 2024 | 5.165B |
| May 28, 2024 | 5.165B |
| May 24, 2024 | 5.165B |
| May 23, 2024 | 5.165B |
| May 22, 2024 | 5.165B |
| Date | Value |
|---|---|
| May 21, 2024 | 5.165B |
| May 20, 2024 | 5.165B |
| May 17, 2024 | 5.165B |
| May 16, 2024 | 5.165B |
| May 15, 2024 | 5.109B |
| May 14, 2024 | 5.109B |
| May 13, 2024 | 5.109B |
| May 10, 2024 | 4.505B |
| May 09, 2024 | 4.505B |
| May 08, 2024 | 4.505B |
| May 07, 2024 | 4.505B |
| May 06, 2024 | 4.505B |
| May 03, 2024 | 4.505B |
| May 02, 2024 | 4.505B |
| May 01, 2024 | 4.505B |
| April 30, 2024 | 4.505B |
| April 29, 2024 | 4.505B |
| April 26, 2024 | 4.505B |
| April 25, 2024 | 4.505B |
| April 24, 2024 | 4.505B |
| April 23, 2024 | 4.473B |
| April 22, 2024 | 4.473B |
| April 19, 2024 | 4.473B |
| April 18, 2024 | 4.473B |
| April 17, 2024 | 4.473B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
2.157B
Minimum
Oct 19 2020
5.385B
Maximum
May 05 2023
3.930B
Average
4.028B
Median
Aug 11 2022
Enterprise Value Benchmarks
| Bangkok Dusit Medical Services PCL | 12.30B |
| NewGenIvf Group Ltd | -- |
| CEL-SCI Corp | 58.60M |
| AIM ImmunoTech Inc | 12.32M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 55.61M |
| Revenue (Quarterly) | 183.12M |
| Total Expenses (Quarterly) | 115.89M |
| EPS Diluted (Quarterly) | 0.0642 |
| Gross Profit Margin (Quarterly) | 51.87% |
| Profit Margin (Quarterly) | 30.36% |
| Earnings Yield | 3.49% |
| Operating Earnings Yield | 4.21% |
| Normalized Earnings Yield | 3.475 |